@Rich&Poor this is incredible information!
If I'm not wrong, this is the premier Alliance GBM trial along with Eli Lilly and Genentech, and little ol'us, Kazia!?
Yet we, with Paxalisib, will have more than 46% of the patients. Sorry but SHIT!!! From that site;
"Brain metastases, most commonly derived from melanoma, lung and breast cancers, are the most common brain tumor, with approximately 200,000 cases diagnosed annually in the United States. "
If what I understand is the assessed cost of this treatment, $100k, well do the figures on that and forget about $1.5b market...
Hahaha... probably too many reds but thanks Rich, I don't think you'll need the other part soon![]()
@Rich&Poor this is incredible information! If I'm not wrong,...
Add to My Watchlist
What is My Watchlist?